Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 05, 2026 08:15 AM ET Company ParticipantsJames Gordon - Director, Head of European Pharma and Biotech & Life Sciences Equity ResearchKarsten Munk Knudsen - CFOMartin Holst Lange - Chief Scientific OfficerMike Doustdar - CEOSachin Jain - European Healthcare Equity ResearchSimon Baker - Head of Global Biopharma ResearchConference Call ParticipantsEvan Seigerman - Managing Director, Head of Healthcare Research, Senior Biotechnology and Pharmaceutical Analy ...